Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Allison Camacho
Observed institution:
Eli Lilly (United States)
OpenAlex ID:
A5005915152
The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes
2021
·
Klara R. Klein
, Jennifer L.R. Freeman
, et al.
·
Diabetes Care
·
43
Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes
2025
·
John B. Buse
, Steven E. Kahn
, et al.
·
Diabetes Care
·
33
PDF
Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment
2025
·
Ralph A. DeFronzo
, Vivian Fonseca
, et al.
·
Diabetes Care
·
23
PDF
A Patient-Driven Approach to Manage Mealtime Insulin Titration
2016
·
Allison Camacho
, Jennal Johnson
, et al.
·
The Science of Diabetes Self-Management and Care
·
1
Show more works
View as search
Works count:
4
Citation count:
100
H-index:
3
I10-index:
3
Year
Topic
Type
